Skip to content

All recalls FDA

FDAMedical devicesRecalled Status: Ongoing

Nipro Renal Soultions USA, Corporation recalls MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Hemodialysis concentrates contain high endotoxin levels
Products
  • MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X
Where it was sold

Worldwide - US Nationwide distribution in the states of FL, GA, IL, MD, MI, NC, NJ, NV, OH, PA, and the countries of Guatemala and Panama.

States: Florida, Georgia, Illinois, Maryland, Michigan, North Carolina, New Jersey, Nevada, Ohio, Pennsylvania

Units affected
2,327 cases
About this recall
MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))